Phase 4
N=58
Study of the Insomnia in Patients With Low Back Pain
Primary Insomnia
Bottom Line
View on ClinicalTrials.gov: NCT00365976 ↗Enrolled (actual)
58
Serious AEs
0.0%
Results posted
Jun 2013
Primary outcome: Primary: Mean Subjective Sleep Diary Derived Total Sleep Time (TST) — 316.96; 380.45; 403.47; 375.56 Minutes
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Eszopiclone (Drug); Placebo (Drug)
- Age
- Adult · 21+ yrs
- Sex
- All
- Sponsor
- Duke University
- Primary completion
- Sep 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Subjective Sleep Diary Derived Total Sleep Time (TST) |
316.96; 380.45; 403.47; 375.56; 421.97; 382.11 | — |
| SECONDARY Visual Analog Scale Pain Ratings (VAS) |
48.51; 53.79; 40.72; 51.99; 34.70; 51.25 | — |
| SECONDARY Mean Sleep Onset Latency (SOL) |
38.28; 34.11; 22.36; 27.00; 17.50; 23.10 | — |
| SECONDARY Wake Time After Sleep Onset |
91.51; 81.43; 49.34; 76.71; 37.07; 81.32 | — |
| SECONDARY Number of Awakenings |
2.29; 2.08; 1.31; 1.98; 1.35; 2.13 | — |
| SECONDARY Sleep Quality Ratings |
4.52; 4.44; 5.99; 4.90; 6.18; 5.33 | — |
| SECONDARY Insomnia Severity Index (ISI) |
18.85; 20.26; 18.00; 16.78; 11.28; 12.85 | — |
| SECONDARY Patient Global Impression of Pain Ratings |
4.02; 3.90; 3.54; 3.82; 3.30; 4.01 | — |
| SECONDARY Roland Morris Low Back Pain Inventory (RMLBPI) |
12.27; 11.33; 9.97; 10.30; 9.10; 9.05 | — |
| SECONDARY Hamilton Depression Rating Scale (HAM-D-24) |
6.45; 7.10; 6.38; 6.57; 4.54; 5.53 | — |
| SECONDARY Short Form 36 Health Survey Questionnaire (SF-36) |
— | — |
| SECONDARY State-Trait Anxiety Inventory (STAI) |
— | — |
Summary
The purpose of this study is to examine whether insomnia due to chronic low back pain can improve with use of eszopiclone.
Eligibility Criteria
Inclusion Criteria
- • Diagnosis of insomnia based on DSM-IV criteria for insomnia due to a general medical condition (low-back pain);
- The insomnia must not predate the onset of low-back pain by more than 1 month;
- Usual nightly TST (Total Sleep Time) 30 minutes for the last month prior to screening;
- ISI (Insomnia Severity Index) > 14 (at least moderate insomnia);
- Age 21-64 years;
- Greater than 40 on VAS (Visual Analog Scale) for pain (scale is 0-no pain to 100-worst imaginable pain);
- Patient Global Impression of Pain of at least 3 (on a 1-5 scale, indicating at least moderate severity);
- reported Back pain must be greater than reported leg pain, and there must be no signs of spinal nerve root compression;
- presence of normal motor strength on exam;
- duration of chronic low back pain of greater than three months;
- low back pain location must be inferior to T12 and superior to the gluteal fold.
Exclusion Criteria
- • Significant medical or neurological illness in excess of that which is directly responsible for the chronic low back pain;
- the presence of an active and significant psychiatric disease with a substantive impact on sleep;
- meeting DSM-IV criteria for an Axis I disorder within the last three months, or meeting criteria for substance abuse within the last 12 months;
- current pregnancy; history of hypersensitivity, intolerance, or contraindication to Naproxen/Lansoprazole or Eszopiclone;
- baseline creatinine of 2.0 or greater; patient taking other medications having significant renal effects (e.g. lithium, ACE inhibitor, angiotensin receptor antagonist, or thiazide/loop diuretics);
- patients taking other anticoagulants; patients having an allergy to aspirin; history of diagnosed gastric or duodenal ulcer;
- history of bleeding or clotting diathesis; lifetime history of myocardial infarction or cerebrovascular accident;
- Elevated PT/PTT/INR (Prothrombin Time, Partial Thromboplastin Time, International Normalized Ratio)at screening;
- Abnormal kidney function detected in screening labs;
- history of back related surgery within the past 3 months; history of corticosteroid use in the past 30 days;
- presence of currently pending litigation or worker's compensation claim related to the chronic low back pain;
- inability to follow study procedures or complete the study; or the use of any medications that could affect sleep within 5 half-lives of screening;
- history of back surgery within the past 2 years with the exception of a discectomy;
- pregnant or lactating females;
- women of child-bearing potential who will not agree to use approved means of birth control during the trial;
- history of any surgery within the past one month; history of any major physical trauma within the last 6 months;
- history of corticosteroid use within the last 90 days; diagnosis of rheumatoid or psoriatic arthritis;
- history of fibromyalgia;
- presence of spondyloarthropathy;
- presence of sciatica;
- spinal stenosis;
- presence of any vertebral fractures, spondylolisthesis; or radicular back pain.
Data sourced from ClinicalTrials.gov (NCT00365976). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.